Lombard Odier Asset Management (USA)’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $284K | Hold |
|
|||||
|
2019
Q3 | $742K | Hold |
|
|||||
|
2019
Q2 | $1.04M | Sell |
|
|||||
|
2019
Q1 | $2.39M | Sell |
|
|||||
|
2018
Q4 | $1.73M | Sell |
|
|||||
|
2018
Q3 | $3.3M | Sell |
|
|||||
|
2018
Q2 | $5.09M | Sell |
|
|||||
|
2018
Q1 | $5.25M | Sell |
|
|||||
|
2017
Q4 | $4.79M | Sell |
|
|||||
|
2017
Q3 | $4.23M | Sell |
|
|||||
|
2017
Q2 | $3.03M | Hold |
|
|||||
|
2017
Q1 | $2.27M | Sell |
|
|||||
|
2016
Q4 | $998K | Sell |
|
|||||
|
2016
Q3 | $1.22M | Sell |
|
|||||
|
2016
Q2 | $1.14M | Sell |
|
|||||
|
2016
Q1 | $958K | Sell |
|
|||||
|
2015
Q4 | $1.83M | Sell |
|
|||||
|
2015
Q3 | $2.13M | Buy |
|
|||||
|
2015
Q2 | $2M | Sell |
|
|||||
|
2015
Q1 | $9.07M | Sell |
|
|||||
|
2014
Q4 | $13.5M | Buy |
|
|||||
|
2014
Q3 | $8.55M | Buy |
|